BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 24, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Vaginal Microbiome Varies Widely, Changes Rapidly

May 4, 2012
By Anette Breindl
Variations in the makeup of the commensal bacteria that colonize our intestines, or gut microbiome, are an intensively studied contributor to health in and beyond the gut. (See BioWorld Today, Jan. 3, 2007, and April 23, 2012.)
Read More

Sodium Channel, Interneurons Could Be Alzheimer's Targets

May 2, 2012
By Anette Breindl
In work that spans molecular to cognitive aspects of Alzheimer's disease, scientists have shown that one of the changes in the brains of mice with Alzheimer's is a reduction in certain types of rhythmic activity that are important for information processing. Increasing levels of one type of sodium channel increased both such rhythmic activity and the animals' learning abilities.
Read More

miRagen's 'Good Problem': Heart Controls Metabolism via miR208a

May 1, 2012
By Anette Breindl
Last week was a busy one for Boulder, Colo.-based miRagen Therapeutics Inc. On Monday, the company announced it had completed a Series B round of $20 million. (See BioWorld Today, April 24, 2012.)
Read More

Aging: New Science, Squeezed Into Same Old Regulatory Path

April 30, 2012
By Anette Breindl
Not very long ago at all, slowing aging was considered a fool's errand. In fact, by many people, it still is. Sure, online ads may show you Photoshopped, or at the very least Photoshopped-looking, pictures of men with wrinkled faces on top of impossibly muscular bodies. But in real life, aging was thought to be inevitable – too complex, and too random, to be significantly stalled by anything as simple as a pill.
Read More

Mitochondria's Bacterial Past Is Problem for Failing Hearts

April 30, 2012
By Anette Breindl
Mitochondria, the energy-producing centers of cells, very likely got their start more than a billion years ago as bacteria that gradually went from a symbiotic relationship to a full-fledged part of the cells they colonized.
Read More

Experimental Diabetes Drug May Be Useful in Muscular Dystrophy

April 25, 2012
By Anette Breindl
Scientists have discovered that an experimental drug currently in clinical trials for diabetes may be useful for the treatment of muscular dystrophy as well.
Read More

In Vaccines and Autism Debates, the Truth is That it's Trust or Consequences

April 24, 2012
By Anette Breindl
Editor’s note: Since Dr. Breindl first wrote about vaccines and autism in 2008, the paper linking the MMR vaccine to autism has been retracted by the journal that published it, and its author Andrew Wakefield has lost his medical license. But vaccine skepticism is alive and well – and so, during this World Immunization Week, the question remains as pressing as ever: How do you have a productive discussion on policy with people who disagree with you on the facts? I am not a vaccine skeptic. My children have all their required vaccines and some optional ones as well. We...
Read More

Simple Model Gives Insight Into SSRI's Cellular Effects

April 24, 2012
By Anette Breindl
Using yeast as a model system, scientists have gained new insights into the effects of selective serotonin reuptake inhibitors (SSRIs) on cells.
Read More

How Immune System Tells Bacterial Friend from Foe

April 20, 2012
By Anette Breindl
The immune system's raison d'être is to protect us from invading microbes. But in the intestines, at least, its chances of encountering bad bugs, which necessitate a vigorous response, are, if not exactly as rare as a lightning strike, then nevertheless the exception rather than the rule.
Read More

Postnatal Treatment Reverses Prenatal Injury in Cerebral Palsy

April 19, 2012
By Anette Breindl
Using nanostructures known as dendrimers to deliver anti-inflammatory drugs across the blood-brain barrier, scientists have been able to improve the symptoms of cerebral palsy in animals. Though still preclinical, that approach, which could also find applications in neurodegenerative diseases, adds cerebral palsy to the growing list of neurodevelopmental disorders that can be at least partially reversed.
Read More
Previous 1 2 … 245 246 247 248 249 250 251 252 253 … 403 404 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 23, 2026.
  • Red CAR T cell on blue blackground

    To viral or not to viral: In vivo CAR T debates delivery tech

    BioWorld
    The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 21, 2026
  • Tree in the shape of human head losing leaves

    KBN-2201 reverses key features of Alzheimer’s in mice

    BioWorld Science
    Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
  • Click chemistry drug bound to pancreatic cancer cells from mice

    In vivo click ADCs could address tumor heterogeneity

    BioWorld
    Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing